71
Participants
Start Date
December 4, 2015
Primary Completion Date
February 28, 2020
Study Completion Date
February 28, 2020
Fulvestrant
Fulvestrant at a dose of 500 mg as two intramuscular injections will be administered on Day 1 and Day 15 of Cycle 1, and on Day 1 of each subsequent 28-day cycle.
GDC-0810
GDC-0810 will be administered as tablets at a dose of 600 mg orally once daily.
St Vincent's Hospital Sydney, Darlinghurst
Port Macquarie Base Hospital, Port Macquarie
Footscray Hospital, Footscray
Epworth HealthCare; Clinical Trials Centre, Richmond
Peninsula and South Eastern Haematology and Oncology Group, Frankston
Adelaide Cancer Centre, Kurralta Park
Royal Hobart Hospital; Medical Oncology, Hobart
National Cancer Center, Goyang-si
Complejo Hospitalario Universitario A Coruña; Servicio de Endocrinologia, A Coruña
Universitätsklinikum Hamburg-Eppendorf, Hamburg
Hospital Universitari Arnau de Vilanova, Lleida
Hospital General Universitario Gregorio Marañon, Madrid
Hospital Universitario Ramon y Cajal, Madrid
Hosp. Clinico San Carlos, Madrid
Hospital Universitario 12 de Octubre, Madrid
Florida Cancer Specialists (St. Petersburg - St. Anthony's Professional Building), St. Petersburg
Florida Cancer Specialists-Broadway, Fort Myers, Fort Myers
Tennessee Oncology PLLC, Franklin
Kyungpook National University Medical Center, Daegu
Ulsan University Hosiptal, Ulsan
Oncology Hematology Care Inc, Cincinnati
Hospital Clinico Universitario de Valencia, Valencia
HELIOS Klinikum Krefeld; Klinik für Frauenheilkunde und Geburtshilfe, Krefeld
Praxisklinik für Hämatologie und Onkologie Dres. Köppler/Heymans/Weide/Thomalla, Koblenz
Marien Hospital Witten Gemeinnützige GmbH, Witten
Universitätsklinikum Tübingen, Tübingen
The Center for Cancer and Blood Disorders - Fort Worth, Fort Worth
MD Anderson Cancer Center, Houston
Rotkreuzklinikum München; Frauenklinik, München
Yale Cancer Center, New Haven
"Universitätsklinikum Carl Gustav Carus der Technischen Universität Dresden", Dresden
Samsung Medical Center, Seoul
Severance Hospital, Yonsei University Health System, Seoul
Korea University Guro Hospital, Seoul
Hospital Clinic, Barcelona
Hospital del Mar, Barcelona
Hospital Universitari Vall d'Hebron, Barcelona
Royal Sussex County Hospital, Brighton
Western General Hospital, Edinburgh
St Bartholomew's Hospital, London
University College Hospital, London
Sarah Cannon Research Institute, London
Macclesfield District General Hospital, Macclesfield
Nottingham City Hospital, Nottingham
Lead Sponsor
Genentech, Inc.
INDUSTRY